Biomaxima - Asset Resilience Ratio

Latest as of June 2023: 0.01%

Biomaxima (BMX) has an Asset Resilience Ratio of 0.01% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Biomaxima debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

zł5.00K

≈ $1.38K USD Cash + Short-term Investments

Total Assets

zł71.24 Million

≈ $19.61 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2022)

This chart shows how Biomaxima's Asset Resilience Ratio has changed over time. See BMX net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Biomaxima's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Biomaxima (BMX) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	zł0.00	0%
Short-term Investments	zł5.00K	0.01%
Total Liquid Assets	zł5.00K	0.01%

Asset Resilience Insights

Limited Liquidity: Biomaxima maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Biomaxima Industry Peers by Asset Resilience Ratio

Compare Biomaxima's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	57.28%
Leveljump Healthcare Corp V:JUMP	Diagnostics & Research	32.45%
Berry Genomics Co Ltd SHE:000710	Diagnostics & Research	0.45%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Biomaxima (2009–2022)

The table below shows the annual Asset Resilience Ratio data for Biomaxima.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.02%	zł13.00K ≈ $3.58K	zł74.42 Million ≈ $20.48 Million	0.00pp
2021-12-31	0.02%	zł13.00K ≈ $3.58K	zł61.93 Million ≈ $17.04 Million	0.00pp
2020-12-31	0.02%	zł13.00K ≈ $3.58K	zł53.43 Million ≈ $14.71 Million	0.00pp
2019-12-31	0.03%	zł12.44K ≈ $3.42K	zł43.30 Million ≈ $11.92 Million	+0.00pp
2018-12-31	0.02%	zł10.94K ≈ $3.01K	zł43.96 Million ≈ $12.10 Million	-0.15pp
2017-12-31	0.18%	zł48.00K ≈ $13.21K	zł27.30 Million ≈ $7.51 Million	-0.16pp
2016-12-31	0.34%	zł78.71K ≈ $21.66K	zł23.42 Million ≈ $6.44 Million	-0.88pp
2015-12-31	1.22%	zł267.04K ≈ $73.49K	zł21.96 Million ≈ $6.04 Million	-0.10pp
2014-12-31	1.31%	zł281.04K ≈ $77.35K	zł21.42 Million ≈ $5.89 Million	-0.14pp
2013-12-31	1.45%	zł327.06K ≈ $90.01K	zł22.60 Million ≈ $6.22 Million	-0.11pp
2012-12-31	1.55%	zł302.78K ≈ $83.33K	zł19.47 Million ≈ $5.36 Million	-0.58pp
2011-12-31	2.14%	zł280.71K ≈ $77.25K	zł13.12 Million ≈ $3.61 Million	+0.23pp
2010-12-31	1.91%	zł200.64K ≈ $55.22K	zł10.50 Million ≈ $2.89 Million	-1.27pp
2009-12-31	3.18%	zł182.40K ≈ $50.20K	zł5.74 Million ≈ $1.58 Million	--

pp = percentage points

About Biomaxima

WAR:BMX Poland Diagnostics & Research

Market Cap

$13.55 Million

zł49.23 Million PLN

Market Cap Rank

#26114 Global

#275 in Poland

Share Price

zł11.74

Change (1 day)

+0.69%

52-Week Range

zł10.90 - zł15.30

All Time High

zł55.45